Cargando…
Evaluation of confirmatory data following the Article 12 MRL review for aclonifen
The applicant Bayer Crop Science submitted a request to the competent national authority in the Netherlands to evaluate the confirmatory data that were identified for aclonifen in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464666/ https://www.ncbi.nlm.nih.gov/pubmed/37649516 http://dx.doi.org/10.2903/j.efsa.2020.6102 |
_version_ | 1785098517706964992 |
---|---|
author | Anastassiadou, Maria Bernasconi, Giovanni Brancato, Alba Carrasco Cabrera, Luis Greco, Luna Jarrah, Samira Kazocina, Aija Leuschner, Renata Magrans, Jose Oriol Miron, Ileana Nave, Stefanie Pedersen, Ragnor Reich, Hermine Rojas, Alejandro Sacchi, Angela Santos, Miguel Stanek, Alois Theobald, Anne Vagenende, Benedicte Verani, Alessia |
author_facet | Anastassiadou, Maria Bernasconi, Giovanni Brancato, Alba Carrasco Cabrera, Luis Greco, Luna Jarrah, Samira Kazocina, Aija Leuschner, Renata Magrans, Jose Oriol Miron, Ileana Nave, Stefanie Pedersen, Ragnor Reich, Hermine Rojas, Alejandro Sacchi, Angela Santos, Miguel Stanek, Alois Theobald, Anne Vagenende, Benedicte Verani, Alessia |
collection | PubMed |
description | The applicant Bayer Crop Science submitted a request to the competent national authority in the Netherlands to evaluate the confirmatory data that were identified for aclonifen in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. To address the data gaps, an analytical method for enforcement in complex/no group matrices (spices) and additional four residue trials supporting SEU authorisation on peppers were submitted. The data gaps were considered satisfactorily addressed and the tentative MRLs can be confirmed in peppers, in seed and fruit spices and in flowers and leaves and herbs of herbal infusions. The previous consumer intake assessment remains valid. |
format | Online Article Text |
id | pubmed-10464666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104646662023-08-30 Evaluation of confirmatory data following the Article 12 MRL review for aclonifen Anastassiadou, Maria Bernasconi, Giovanni Brancato, Alba Carrasco Cabrera, Luis Greco, Luna Jarrah, Samira Kazocina, Aija Leuschner, Renata Magrans, Jose Oriol Miron, Ileana Nave, Stefanie Pedersen, Ragnor Reich, Hermine Rojas, Alejandro Sacchi, Angela Santos, Miguel Stanek, Alois Theobald, Anne Vagenende, Benedicte Verani, Alessia EFSA J Reasoned Opinion The applicant Bayer Crop Science submitted a request to the competent national authority in the Netherlands to evaluate the confirmatory data that were identified for aclonifen in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. To address the data gaps, an analytical method for enforcement in complex/no group matrices (spices) and additional four residue trials supporting SEU authorisation on peppers were submitted. The data gaps were considered satisfactorily addressed and the tentative MRLs can be confirmed in peppers, in seed and fruit spices and in flowers and leaves and herbs of herbal infusions. The previous consumer intake assessment remains valid. John Wiley and Sons Inc. 2020-05-15 /pmc/articles/PMC10464666/ /pubmed/37649516 http://dx.doi.org/10.2903/j.efsa.2020.6102 Text en © 2020 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. https://creativecommons.org/licenses/by-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ (https://creativecommons.org/licenses/by-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made. |
spellingShingle | Reasoned Opinion Anastassiadou, Maria Bernasconi, Giovanni Brancato, Alba Carrasco Cabrera, Luis Greco, Luna Jarrah, Samira Kazocina, Aija Leuschner, Renata Magrans, Jose Oriol Miron, Ileana Nave, Stefanie Pedersen, Ragnor Reich, Hermine Rojas, Alejandro Sacchi, Angela Santos, Miguel Stanek, Alois Theobald, Anne Vagenende, Benedicte Verani, Alessia Evaluation of confirmatory data following the Article 12 MRL review for aclonifen |
title | Evaluation of confirmatory data following the Article 12 MRL review for aclonifen |
title_full | Evaluation of confirmatory data following the Article 12 MRL review for aclonifen |
title_fullStr | Evaluation of confirmatory data following the Article 12 MRL review for aclonifen |
title_full_unstemmed | Evaluation of confirmatory data following the Article 12 MRL review for aclonifen |
title_short | Evaluation of confirmatory data following the Article 12 MRL review for aclonifen |
title_sort | evaluation of confirmatory data following the article 12 mrl review for aclonifen |
topic | Reasoned Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464666/ https://www.ncbi.nlm.nih.gov/pubmed/37649516 http://dx.doi.org/10.2903/j.efsa.2020.6102 |
work_keys_str_mv | AT evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT anastassiadoumaria evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT bernasconigiovanni evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT brancatoalba evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT carrascocabreraluis evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT grecoluna evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT jarrahsamira evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT kazocinaaija evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT leuschnerrenata evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT magransjoseoriol evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT mironileana evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT navestefanie evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT pedersenragnor evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT reichhermine evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT rojasalejandro evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT sacchiangela evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT santosmiguel evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT stanekalois evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT theobaldanne evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT vagenendebenedicte evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen AT veranialessia evaluationofconfirmatorydatafollowingthearticle12mrlreviewforaclonifen |